This Focus issue on atrial fibrillation (AF) contains three specially commissioned Review articles, written by leaders in the field, on promising new developments in catheter ablation, atrial antiarrhythmic drug therapy, and anticoagulants for stroke prevention in patients with AF. The issue also features News & Views commentaries, a Research Highlight, and an Editorial, discussing important advances in AF research that have been reported in the past few months.